Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 630 record(s)

Req # A-2024-000017

Adverse Drug Reaction (ADR) for ACITRETIN. Report number: 1071472. ADRs for ANASTROZOLE. Report numbers: 983160, 990116. ADR for CIPROFLOX. Report number: 1032025. ADR for Clonidine. Report number: 981372. ADRs for EPLERENONE. Reports number: 1026516, 1043922. ADRs for HYDROXYCHLOROQUINE. Report numbers: 1024918, 1026702, 1037377.

Organization: Health Canada

70 page(s)
April 2024

Req # A-2024-000028

Adverse Drug Reactions (ADRs) for Rosuvastatin-40. Report numbers: 000657015, 000702528. ADRs for Rosuvastatin-10. Report numbers: 000675846, 000928844. ADRs for Rosuvastatin-5. Report numbers: 000698101, 000705573. ADRs for Rosuvastatin-20. Report numbers: 000709470, 000720165.

Organization: Health Canada

29 page(s)
April 2024

Req # A-2024-000032

Adverse Drug Reactions (ADRs) for IBUPROFEN. Report numbers: 001049833, 001051635, 001052031, 001052040, 001052619, 001050859, 001053224, 001055320, 001065019, 001065607.

Organization: Health Canada

76 page(s)
April 2024

Req # A-2024-000068

Adverse Drug Reaction (ADR) for YESCARTA. Report number: 001076510.

Organization: Health Canada

3 page(s)
April 2024

Nothing to report this month

Organization: First Nations Tax Commission

April 2024

Req # A-2019-02185

Information regarding mining in the State of Guerrero at the EL Limon - Guajes mine. A calendar or timeline of any meetings requested or that have taken place which included members of the Canadian mission in Mexico between January 2016 and January 9, 2020.

Organization: Global Affairs Canada

5 page(s)
April 2023

Req # A-2019-02584

Records noted as Other Analyses prepared by Allan Culham, Special Advisor on Venezuela, for Assistant Deputy Minister level and above between September 2017 and December 19, 2020.

Organization: Global Affairs Canada

50 page(s)
April 2023

Req # A-2020-00186

Briefing note 00012-2019: Financing Request for Arctic Gateway Group Limited Partnership for the Acquisition of the Hudson Bay Railway and Port of Churchill Facilities.

Organization: Global Affairs Canada

40 page(s)
April 2023

Req # A-2020-00836

Briefing note 00250-2020: Tabling in the House of Commons of the Memorandum of Understanding between the United Nations and Canada Contributing Resources to the United Nations Multidimensional Integrated Stabilization Mission in Mali.

Organization: Global Affairs Canada

320 page(s)
April 2023

Req # A-2021-00854

Records and correspondences by officials at the Director General, Assistant Deputy Minister or Deputy Minister level regarding or discussing the contents and recommendations of department’s evaluation of the Mission Cultural Fund.

Organization: Global Affairs Canada

8 page(s)
April 2023
Date modified: